Skip to main content
. 2023 Sep 22;11(10):2593. doi: 10.3390/biomedicines11102593

Figure 2.

Figure 2

(A) Pain level during wound healing (verbal rating scale 0–10) showing significantly less pain after the application of Suprathel® compared to the use of Jelonet® on day 2 and day 4 using a two-sample t-test (mean ± SEM; ** indicating p < 0.01 and *** indicating p < 0.001). (B) Exudation during wound healing (analyzed by the visual inspection of an observer who was blinded to the treatment). The area under the curve analysis shows significantly lower exudation after applying Suprathel® than after applying Jelonet®. (C) Bleeding during wound healing (analyzed by the visual inspection of an observer who was blinded to the treatment). The area under the curve analysis shows significantly lower bleeding rates in the Suprathel® areas with no bleeding being observed.